tiprankstipranks
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ:TARS
US Market
TARS
Tarsus Pharmaceuticals
RESEARCH TOOLSreports
Want to see TARS full AI Analyst Report?

Tarsus Pharmaceuticals (TARS) Revenue

270 Followers
StatisticsMarket CapRevenue

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had a revenue of 162.05M in the quarter ending Mar 31, 2026, with 6.85%. This bring the company's revenue in the last twelve months to 535.08M, Decreased 18.55%. In the fiscal year ending Dec 31, 2025, Tarsus Pharmaceuticals had annual revenue of 451.36M with 146.71% growth.
Revenue (ttm)
535.08M
Revenue Growth
128.99%
P/S Ratio
5.99
Revenue/Employee
$1,397,399
Employees
323
Market Cap
$2.70B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
451.36M268.41M+146.71%
Dec 31, 2024
182.95M165.51M+948.62%
Dec 31, 2023
17.45M-8.37M-32.42%
Dec 31, 2022
25.82M-31.21M-54.73%
Dec 31, 2021
57.03M―+∞%
Dec 31, 2020
―――
Dec 31, 2019
―――
Dec 31, 2018
―――